Unnamed: 0,title,date,stock,sentiment
666373.0,Infinity Pharma Shares Spike To Session High On Volume Following Criculation Of US PTO Abstract 'Compounds and pharmaceutical compositions that modulate kinase activity',2020-06-09 14:13:00-04:00,INFI,positive
666374.0,"B. Riley FBR Maintains Buy on Infinity Pharmaceuticals, Lowers Price Target to $2.5",2020-05-18 07:39:00-04:00,INFI,negative
666375.0,"Wells Fargo Maintains Equal-Weight on Infinity Pharmaceuticals, Lowers Price Target to $1",2020-05-12 08:25:00-04:00,INFI,positive
666376.0,Infinity Pharmaceuticals Q1 EPS $(0.190) Misses $(0.130) Estimate,2020-05-11 07:36:00-04:00,INFI,negative
666377.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,INFI,neutral
666378.0,88 Biggest Movers From Yesterday,2020-03-26 04:07:00-04:00,INFI,neutral
666379.0,62 Stocks Moving In Wednesday's Mid-Day Session,2020-03-25 12:16:00-04:00,INFI,neutral
666380.0,Why Infinity Pharmaceutical's Stock Is Trading Higher Today,2020-03-25 08:37:00-04:00,INFI,neutral
666381.0,Infinity Receives Fast Track Designation For IPI-549 In Combination With The Checkpoint Inhibitor Opdivo For The Treatment Of Advanced Urothelial Cancer,2020-03-25 07:35:00-04:00,INFI,negative
666382.0,"Wells Fargo Maintains Equal-Weight on Infinity Pharmaceuticals, Lowers Price Target to $1.5",2020-03-04 08:07:00-05:00,INFI,positive
666383.0,"Infinity Pharmaceuticals Q4 EPS $(0.83) Down From $(0.2) YoY, Sales $3.049K Down From $22.146K YoY",2020-03-03 16:09:00-05:00,INFI,neutral
666384.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,INFI,positive
666385.0,"The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off",2020-02-29 14:52:00-05:00,INFI,neutral
666386.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,INFI,neutral
666387.0,Infinity Pharmaceuticals Sees FY20 Net Loss $40M-$50M; Issues Development Guidance,2020-01-13 07:44:00-05:00,INFI,negative
666388.0,Infinity Pharma Reports Raising Of $20M Non-Dilutive Asset-Backed Financing From BVF,2020-01-09 07:35:00-05:00,INFI,neutral
666389.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",2019-11-08 08:14:00-05:00,INFI,neutral
666390.0,"Infinity Pharmaceuticals Q3 EPS $(0.2) Misses $(0.1) Estimate, Sales $343K Down From $22M YoY",2019-10-30 17:19:00-04:00,INFI,negative
666391.0,"The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo",2019-10-03 07:34:00-04:00,INFI,negative
666392.0,Infinity Pharmaceuticals Announces The Initiation Of Two Clinical Trials Evaluating IPI-549 In Novel Triple Combination Therapies For The Treatment Of Solid Tumors,2019-09-04 08:34:00-04:00,INFI,positive
666393.0,"Infinity Pharmaceuticals Q2 EPS $(0.18) May Not Compare To $0.08 Estimate, Sales $257M Beat $192.26M Estimate",2019-07-30 07:46:00-04:00,INFI,neutral
666394.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,INFI,positive
666395.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,INFI,negative
666396.0,"Oppenheimer Initiates Coverage On Infinity Pharmaceuticals with Outperform Rating, Announces $3 Price Target",2019-06-27 07:01:00-04:00,INFI,neutral
666397.0,Infinity Pharma Sees FY19 Net Loss $40M-$50M,2019-05-07 16:55:00-04:00,INFI,negative
666398.0,"Infinity Pharmaceuticals Q1 EPS $(0.24) Misses $(0.05) Estimate, Sales $2.142M Miss $6.67M Estimate",2019-05-07 16:54:00-04:00,INFI,negative
666399.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,INFI,neutral
666400.0,Infinity Pharmaceuticals To Present At The 18th Annual Needham Healthcare Conference,2019-04-02 08:32:00-04:00,INFI,neutral
666401.0,"Infinity Pharmaceuticals Q4 EPS $(0.14) Beats $(0.17) Estimate, Sales $146K Beat $10K Estimate",2019-03-14 07:46:00-04:00,INFI,neutral
666402.0,"Infinity Pharma To Initiate Phase 2 Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer, Renal Cell Cancer",2019-03-14 07:03:00-04:00,INFI,negative
666403.0,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",2019-03-13 07:27:00-04:00,INFI,negative
666404.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,INFI,neutral
666405.0,45 Stocks Moving In Wednesday's Mid-Day Session,2019-03-06 12:27:00-05:00,INFI,neutral
666406.0,"Infinity Pharmaceuticals shares are trading higher after the company announced an agreement for the right to receive royalty payments on sales of COPIKTRA, payable by Verastem.",2019-03-06 08:10:00-05:00,INFI,positive
666407.0,Infinity Pharmaceuticals Announces Royalty Monetization Of COPIKTRA For $30M Gross Proceeds,2019-03-06 07:41:00-05:00,INFI,negative
666408.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2019",2019-01-04 09:14:00-05:00,INFI,positive
666409.0,"B. Riley FBR Initiates Coverage On Infinity Pharmaceuticals with Buy Rating, Announces $3 Price Target",2019-01-04 08:06:00-05:00,INFI,neutral
666410.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,INFI,neutral
666411.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018",2018-12-14 11:03:00-05:00,INFI,negative
666412.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,INFI,negative
666413.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018",2018-11-29 10:59:00-05:00,INFI,negative
666414.0,"The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut",2018-11-13 07:54:00-05:00,INFI,negative
666415.0,70 Biggest Movers From Yesterday,2018-11-13 04:46:00-05:00,INFI,neutral
666416.0,Mid-Afternoon Market Update: OPKO Health Rises On Q3 Earnings; Lumentum Shares Plummet,2018-11-12 14:24:00-05:00,INFI,positive
666417.0,54 Stocks Moving In Monday's Mid-Day Session,2018-11-12 12:38:00-05:00,INFI,neutral
666418.0,Mid-Day Market Update: Dow Down Over 400 Points; Apptio Shares Spike Higher,2018-11-12 12:05:00-05:00,INFI,positive
666419.0,Mid-Morning Market Update: Markets Open Lower; Veritas Capital To Buy Athenahealth For $5.7B,2018-11-12 10:26:00-05:00,INFI,negative
666420.0,"Benzinga's Top Upgrades, Downgrades For November 12, 2018",2018-11-12 09:17:00-05:00,INFI,positive
666421.0,Wells Fargo Downgrades Infinity Pharmaceuticals to Market Perform,2018-11-12 08:34:00-05:00,INFI,positive
666422.0,JP Morgan Downgrades Infinity Pharmaceuticals to Underweight,2018-11-12 05:46:00-05:00,INFI,positive
666423.0,"The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering",2018-11-06 07:04:00-05:00,INFI,positive
666424.0,Infinity Pharma Sees FY18 Loss $20M-$10M,2018-11-05 16:48:00-05:00,INFI,negative
666425.0,"Infinity Pharmaceuticals, Inc. Q3 EPS $0.23 Beats $(0.15) Estimate, Sales $22M Up From $6M YoY",2018-11-05 16:25:00-05:00,INFI,neutral
666426.0,Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo in Combination with IPI-549 in Urothelial Cancer,2018-11-05 07:22:00-05:00,INFI,negative
666427.0,"Bristol-Myers, Infinity Pharma Report New Clinical Collaboration To Evaluate Opdivo In Combo With IPI-549 For Urothelial Cancer",2018-11-05 06:59:00-05:00,INFI,negative
666428.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,INFI,neutral
666429.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,INFI,neutral
666430.0,UPDATE: Infinity Pharma Press Release Did Not Include Any Details About What Will Be Discussed During Late-Breaker Presentation For SITC Meeting,2018-11-01 14:25:00-04:00,INFI,neutral
666431.0,Infinity Pharma Shares Spike ~$0.10 Higher On Volume As Co. Issues Release Highlighting Its IPI-549 Will Be Featured As Late-Breaking Presentation at The Society For Immunotherapy Of Cancer Meeting Nov. 7-11,2018-11-01 14:25:00-04:00,INFI,negative
666432.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-10-09 08:19:00-04:00,INFI,neutral
666433.0,45 Biggest Movers From Yesterday,2018-10-03 05:40:00-04:00,INFI,neutral
666434.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-10-02 13:51:00-04:00,INFI,neutral
666435.0,"Infinity Pharma Receives a $22M Milestone Payment From Versatem Oncology Following FDA Approval of COPIKTRA, Sees 2018 Net Loss From $10M to $20M",2018-10-01 08:37:00-04:00,INFI,positive
666436.0,51 Biggest Movers From Yesterday,2018-09-11 05:05:00-04:00,INFI,neutral
666437.0,54 Biggest Movers From Yesterday,2018-09-06 05:13:00-04:00,INFI,neutral
666438.0,Infinity Pharmaceuticals Q2 EPS $(0.12) Beats $(0.20) Estimate,2018-08-07 17:13:00-04:00,INFI,neutral
666439.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,INFI,negative
666440.0,Arcus Bioscience Reports Clinical Collaboration With Infinity Pharma To Evaluate 2 Triple Combo Therapies In Selected Tumor Types,2018-06-26 08:32:00-04:00,INFI,negative
666441.0,"Seaport Global Initiates Coverage On Infinity Pharmaceuticals with Buy Rating, Announces $4 Price Target",2018-05-31 09:03:00-04:00,INFI,neutral
666442.0,"Infinity Pharmaceuticals Q1 EPS $(0.18), Inline",2018-05-08 15:44:00-04:00,INFI,neutral
666443.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,INFI,neutral
666444.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,INFI,neutral
666445.0,"Infinity Pharmaceuticals Shares Down 4.1% Afer Hours Following Filing Of 1,134,689 Share Common Stock Offering By Selling Stockholders",2018-04-30 17:42:00-04:00,INFI,positive
666446.0,"Infinity Pharma Files For 1,134,689 Share Common Stock Offering By Selling Stockholders",2018-04-30 17:20:00-04:00,INFI,positive
666447.0,48 Biggest Movers From Friday,2018-03-19 06:01:00-04:00,INFI,neutral
666448.0,36 Stocks Moving In Friday's Mid-Day Session,2018-03-16 12:35:00-04:00,INFI,neutral
666449.0,Infinity Pharma Reports Q4 EPS $(0.14) vs $(0.25) Est.; Sees FY18 Net Loss $45M-435M,2018-03-15 16:41:00-04:00,INFI,negative
666450.0,"Earnings Scheduled For March 15, 2018",2018-03-15 04:17:00-04:00,INFI,neutral
666451.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-11 16:58:00-04:00,INFI,neutral
666452.0,44 Biggest Movers From Yesterday,2018-03-07 05:03:00-05:00,INFI,neutral
666453.0,Mid-Afternoon Market Update: Freshpet Slides On Earnings Miss; CommerceHub Shares Surge,2018-03-06 14:30:00-05:00,INFI,positive
666454.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-03-06 12:27:00-05:00,INFI,neutral
666455.0,25 Stocks Moving In Tuesday's Pre-Market Session,2018-03-06 08:09:00-05:00,INFI,neutral
666456.0,32 Biggest Movers From Yesterday,2018-03-06 05:08:00-05:00,INFI,neutral
666457.0,25 Stocks Moving In Tuesday's Pre-Market Session,2018-01-09 08:29:00-05:00,INFI,neutral
666458.0,44 Biggest Movers From Friday,2017-11-13 05:41:00-05:00,INFI,neutral
666459.0,35 Stocks Moving In Friday's Mid-Day Session,2017-11-10 12:41:00-05:00,INFI,neutral
666460.0,Mid-Day Market Update: Omeros Climbs After Strong Q3 Results; LightPath Technologies Shares Plunge,2017-11-10 12:00:00-05:00,INFI,positive
666461.0,Mid-Morning Market Update: Markets Open Lower; J C Penney Sales Beat Estimates,2017-11-10 10:10:00-05:00,INFI,negative
666462.0,Infinity Pharmaceuticals Earlier Reported Phase 1/1b Study Results Showing IPI-549 Was Was Well Tolerated and Demonstrated Clinical Activity,2017-11-10 10:00:00-05:00,INFI,positive
666463.0,31 Stocks Moving In Friday's Pre-Market Session,2017-11-10 08:19:00-05:00,INFI,neutral
666464.0,45 Stocks Moving In Tuesday's Mid-Day Session,2017-11-07 12:41:00-05:00,INFI,neutral
666465.0,"Infinity Pharma Sees FY17 Net Loss $40M-$50M, End Of Year Cash, Cash Equivalents, Etc $40M-$50M",2017-11-07 08:47:00-05:00,INFI,negative
666466.0,40 Stocks Moving In Tuesday's Pre-Market Session,2017-11-07 08:07:00-05:00,INFI,neutral
666467.0,"Infinity Reports Q3 EPS $(0.14) vs $(0.21) Est., Sales $6M",2017-11-07 08:02:00-05:00,INFI,neutral
666468.0,38 Biggest Movers From Yesterday,2017-10-19 04:45:00-04:00,INFI,neutral
666469.0,32 Stocks Moving In Wednesday's Mid-Day Session,2017-10-18 12:53:00-04:00,INFI,neutral
666470.0,38 Biggest Movers From Friday,2017-10-16 04:39:00-04:00,INFI,neutral
666471.0,Mid-Afternoon Market Update: Applied Optoelectronics Drops On Q3 Warning; PhaseRx Shares Surge,2017-10-13 14:31:00-04:00,INFI,negative
666472.0,35 Stocks Moving In Friday's Mid-Day Session,2017-10-13 12:31:00-04:00,INFI,neutral
666473.0,Mid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares Plunge,2017-10-13 12:02:00-04:00,INFI,positive
666474.0,Mid-Morning Market Update: Markets Open Higher; Bank of America Profit Beats Expectations,2017-10-13 10:14:00-04:00,INFI,positive
666475.0,28 Stocks Moving In Friday's Pre-Market Session,2017-10-13 08:03:00-04:00,INFI,neutral
666476.0,Mid-Afternoon Market Update: Crude Oil Down 2%; Infinity Pharmaceuticals Shares Spike Higher,2017-10-12 14:30:00-04:00,INFI,negative
666477.0,33 Stocks Moving In Thursday's Mid-Day Session,2017-10-12 12:40:00-04:00,INFI,neutral
666478.0,Infinity Pharmaceuticals Notches Upgrade Ahead Of Cancer Conference Presentation,2017-10-12 12:27:00-04:00,INFI,negative
666479.0,Mid-Day Market Update: J.Jill Tumbles Following Weak Q3 Outlook; Ardelyx Shares Surge,2017-10-12 12:22:00-04:00,INFI,negative
666480.0,"Adam Feuerstein Issues Correction To Last Tweet: In today's edition of ""WTF Biotech Stock Market Follies"" $INFI +65% on SITC late breaker of yet another Pi3K. Plus, a Birch upgrade.",2017-10-12 10:36:00-04:00,INFI,negative
666481.0,Mid-Morning Market Update: Markets Edge Lower; JPMorgan Profit Beats Estimates,2017-10-12 10:14:00-04:00,INFI,positive
666482.0,"Benzinga's Top Upgrades, Downgrades For October 12, 2017",2017-10-12 09:14:00-04:00,INFI,positive
666483.0,Wells Fargo Upgrades Infinity Pharmaceuticals to Outperform,2017-10-12 08:09:00-04:00,INFI,positive
666484.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-10-12 08:03:00-04:00,INFI,neutral
666485.0,Infinity Pharma Announces an IPI-549 Late-Breaking Presentation at SITC Annual Meeting,2017-10-12 07:51:00-04:00,INFI,neutral
666486.0,"Infinity Pharmaceuticals 10%+ Owner Mark Lampert Buys 1,600,046 @ Avg Price: $1.26 -Form4",2017-10-06 04:18:00-04:00,INFI,neutral
666487.0,Infinity Pharma and Bristol-Myers Expand Clinical Collaboration Evaluating IPI-549 in Combination with Opdivo,2017-09-25 08:03:00-04:00,INFI,positive
666488.0,Infinity Pharmaceuticals Reports Q1 EPS $(0.21) vs $(0.27) Est.,2017-05-09 17:09:00-04:00,INFI,neutral
666489.0,Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop,2017-04-18 15:08:00-04:00,INFI,positive
666490.0,Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates,2017-04-18 10:00:00-04:00,INFI,negative
666491.0,15 Biggest Mid-Day Gainers For Monday,2017-04-03 12:40:00-04:00,INFI,neutral
666492.0,22 Stocks Moving In Monday's Pre-Market Session,2017-04-03 08:35:00-04:00,INFI,neutral
666493.0,Infinity Pharmaceuticals Presents Updated Phase 1 Data for IPI-549 Presented at AACR 2017,2017-04-02 09:34:00-04:00,INFI,neutral
666494.0,Infinity Reports Q4 EPS $(0.46) vs. $(0.57) Est.,2017-03-14 16:08:00-04:00,INFI,neutral
666495.0,"Earnings Scheduled For March 14, 2017",2017-03-14 04:44:00-04:00,INFI,neutral
666496.0,25 Biggest Mid-Day Gainers For Thursday,2017-03-02 12:39:00-05:00,INFI,neutral
666497.0,Mid-Morning Market Update: Markets Edge Lower; Abercrombie & Fitch Earnings Miss Views,2017-03-02 10:00:00-05:00,INFI,negative
666498.0,15 Biggest Mid-Day Gainers For Monday,2017-01-23 12:30:00-05:00,INFI,neutral
666499.0,20 Stocks Moving In Monday's Pre-Market Session,2017-01-23 08:19:00-05:00,INFI,neutral
666500.0,"Infinity Sees FY17 Cash Of $92.1M, Sees Loss Of $40-$50M",2017-01-09 08:14:00-05:00,INFI,negative
666501.0,6 Worst Biotech Stocks Of 2016,2016-12-23 11:50:00-05:00,INFI,negative
666502.0,"10 Stocks That Rallied Four Days, Then Sold Off Yesterday",2016-12-08 05:15:00-05:00,INFI,neutral
666503.0,10 Stocks That Rallied Three Days On Increasing Volume,2016-11-11 07:10:00-05:00,INFI,neutral
666504.0,Infinity Reports Q3 EPS $(0.39) vs. Est. $(0.86),2016-11-09 17:04:00-05:00,INFI,neutral
666505.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,INFI,neutral
666506.0,Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo in Combination with IPI-549 in Advanced Solid Tumors,2016-11-09 07:13:00-05:00,INFI,positive
666507.0,10 Stocks That Plummeted The Past Three Days On Increasing Volume,2016-11-07 07:11:00-05:00,INFI,neutral
666508.0,Verastem Licenses Duvelisib from Infinity Pharmaceuticals,2016-11-02 06:52:00-04:00,INFI,neutral
666509.0,"Infinity Pharma Reports Prelim. Phase 1 Results from Nine Patients Using IPI-549 Showed Safety, Pharmacokinetic, Pharmacodynamics Appear Favorable",2016-09-26 17:17:00-04:00,INFI,positive
666510.0,"25 Stocks Which Rallied Four Days, Then Sold Off Yesterday",2016-09-22 09:47:00-04:00,INFI,neutral
666511.0,The Biggest Pharma Stock Blowups Of 2016,2016-09-19 14:52:00-04:00,INFI,neutral
666512.0,Infinity Pharma Spikes to High of $1.61 on Volume,2016-09-02 10:18:00-04:00,INFI,neutral
666513.0,"Infinity Pharmaceuticals Reports Q2 EPS $1.05 Does Not Compare To $(0.89) Estimate, Rev. $9.467M",2016-08-09 16:34:00-04:00,INFI,neutral
666514.0,"UPDATE: Infinity Pharma to Cut ~58% of Global Workforce, or ~100 Employees",2016-06-28 07:01:00-04:00,INFI,negative
666515.0,"Infinity Pharma Reports Regained Global Rights to Duvelisib; Will Explore Strategic Options for Program, Will Undertake Wokrforce Restructuring",2016-06-28 07:01:00-04:00,INFI,neutral
666516.0,Infinity Pharma IR Tells Benzinga That The Company Canceled Out Of JMP Conf. Due To Ongoing Business Discussions With Partner Abbvie On duvelisib,2016-06-21 11:14:00-04:00,INFI,neutral
666517.0,Infinity Pharma Says They Will Not Be Attending JMP Conference,2016-06-21 07:37:00-04:00,INFI,neutral
666518.0,Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Bob Evans Farms Shares Drop Following Weak Forecast,2016-06-15 14:37:00-04:00,INFI,negative
666519.0,10 Biggest Mid-Day Gainers For Wednesday,2016-06-15 12:31:00-04:00,INFI,neutral
666520.0,Infinity Pharmaceuticals Spikes to High on Vol,2016-06-15 11:54:00-04:00,INFI,neutral
666521.0,7 Largest Price Target Changes For Wednesday,2016-06-15 09:29:00-04:00,INFI,neutral
666522.0,Benzinga's Top Downgrades,2016-06-15 09:03:00-04:00,INFI,positive
666523.0,12 Stocks Moving In Wednesday's Pre-Market Session,2016-06-15 08:25:00-04:00,INFI,neutral
666524.0,Infinity Pharma At Risk Of AbbVie 'Walking Away',2016-06-15 08:08:00-04:00,INFI,negative
666525.0,William Blair Downgrades Infinity Pharmaceuticals to Market Perform,2016-06-15 07:47:00-04:00,INFI,neutral
666526.0,Wells Fargo Downgrades Infinity Pharmaceuticals to Market Perform,2016-06-15 07:36:00-04:00,INFI,positive
666527.0,Jefferies Downgrades Infinity Pharmaceuticals to Hold,2016-06-15 07:15:00-04:00,INFI,neutral
666528.0,"Morgan Stanley Downgrades Infinity Pharmaceuticals to Equal-weight, Lowers PT to $1.00",2016-06-15 04:00:00-04:00,INFI,negative
666529.0,Mid-Afternoon Market Update: Crude Oil Down Over 1%; Motorcar Parts of America Shares Spike Higher,2016-06-14 14:38:00-04:00,INFI,negative
666530.0,JMP Securities Downgrades Infinity Pharmaceuticals to Market Perform,2016-06-14 14:26:00-04:00,INFI,positive
666531.0,9 Biggest Mid-Day Losers For Tuesday,2016-06-14 13:06:00-04:00,INFI,negative
666532.0,"Wedbush Upgrades Infinity Pharmaceuticals to Neutral, Lowers PT to $1.50",2016-06-14 12:21:00-04:00,INFI,negative
666533.0,Infinity Pharma Shares Run Into Resistance at $1.30 Following Intraday Upgrade to Neutral from Wedbush,2016-06-14 12:20:00-04:00,INFI,positive
666534.0,Mid-Day Market Update: Yingli Green Energy Surges Following Q1 Earnings; Infinity Pharmaceuticals Shares Tumble,2016-06-14 12:08:00-04:00,INFI,positive
666535.0,Stocks Hitting 52-Week Lows,2016-06-14 10:25:00-04:00,INFI,negative
666536.0,Mid-Morning Market Update: Markets Mostly Lower; Isle of Capri Casinos Profit Beats Views,2016-06-14 10:06:00-04:00,INFI,positive
666537.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-06-14 08:19:00-04:00,INFI,neutral
666538.0,Infinity Expects to Provide Updated 2016 Financial Guidance Following Resolution of Strategic Activities; Says Previous 2016 Financial Guidance Should No Longer be Relied Upon,2016-06-14 05:59:00-04:00,INFI,negative
666539.0,"Infinity is Undertaking a Strategic Restructuring that will Close Down its Discovery Research Organization, Impacting 21% of Workforce",2016-06-14 05:58:00-04:00,INFI,neutral
666540.0,"Infinity, AbbVie are in Ongoing, Collaborative Discussions to Explore Next Steps for the Parties' Collaboration",2016-06-14 05:56:00-04:00,INFI,positive
666541.0,Infinity Pharmaceuticals Announces DYNAMO Phase 2 Monotherapy Study Evaluating the Efficacy and Safety of Duvelisib Met Primary Endpoint,2016-06-14 05:54:00-04:00,INFI,positive
666542.0,3 Biotechs Posting Big Moves In Monday's After-Hours Session,2016-06-13 16:50:00-04:00,INFI,neutral
666543.0,Mid-Day Market Update: TETRA Technologies Drops Following Weak Results; Krispy Kreme Shares Spike Higher,2016-05-09 12:32:00-04:00,INFI,negative
666544.0,Infinity Reports Q1 Rev. $9.25M vs. Est. $8.8M,2016-05-04 16:13:00-04:00,INFI,neutral
666545.0,Infinity Reports Q1 EPS $(0.82) vs. Est. $(0.82),2016-05-04 16:12:00-04:00,INFI,neutral
666546.0,"Infinity Pharma Reports IPI-549 Alters the Immune-Suppressive Microenvironment, Enhances Activity of Checkpoint Inhibitors in Preclinical Models",2016-04-18 08:11:00-04:00,INFI,negative
666547.0,Mid-Day Market Update: U.S. Stocks Rise; Cree Shares Decline On Weak Outlook,2016-04-06 12:06:00-04:00,INFI,negative
666548.0,Mid-Morning Market Update: Markets Mixed; Monsanto Posts Lower Q2 Profit,2016-04-06 09:49:00-04:00,INFI,positive
666549.0,"Wedbush Downgrades Infinity Pharma To Underperform, Slashes Target To $3",2016-03-22 13:31:00-04:00,INFI,negative
666550.0,Mid-Day Market Update: Mattress Firm Drops Following Weak Results; NQ Mobile Shares Surge,2016-03-22 12:05:00-04:00,INFI,negative
666551.0,Mid-Morning Market Update: Markets Open Lower; G-III Apparel Misses Q4 Expectations,2016-03-22 09:49:00-04:00,INFI,negative
666552.0,Benzinga's Top Downgrades,2016-03-22 08:40:00-04:00,INFI,positive
666553.0,"Wedbush Downgrades Infinity Pharmaceuticals to Underperform, Lowers PT to $3.00",2016-03-22 07:42:00-04:00,INFI,negative
666554.0,Benzinga's Top Initiations,2016-03-02 09:45:00-05:00,INFI,positive
666555.0,FBR Capital Initiates Coverage on Infinity Pharmaceuticals at Outperform,2016-03-02 07:14:00-05:00,INFI,neutral
666556.0,"Infinity Pharma Reports Q4 EPS $(0.80) vs $(0.72) Est., Sales $9.08M vs $18.3M Est.",2016-02-23 16:23:00-05:00,INFI,neutral
666557.0,Infinity Pharma Sees FY 2016 Revs $225M-$245M Vs Est $174M,2016-02-23 16:02:00-05:00,INFI,neutral
666558.0,Infinity Pharma. Files $100M Mixed Shelf Offering,2016-02-23 15:39:00-05:00,INFI,neutral
666559.0,What Arista's Beat And Raise Report Means For Network Peers,2016-02-19 10:03:00-05:00,INFI,neutral
666560.0,13G Filings Shows Infinity Pharma Holder Goldman Sachs Asset Mgmt LP Holds 5.6% Stake As Of Dec 31,2016-01-11 16:49:00-05:00,INFI,positive
666561.0,"Infinity Pharmaceuticals Sees FY2016 Sales $225.0M-245.0M vs $121.46M Est, May Not Compare",2016-01-11 08:09:00-05:00,INFI,neutral
666562.0,Mid-Afternoon Market Update: Crude Oil Slides Over 2%; MannKind Shares Dip On Termination Of Afrezza Deal With Sanofi,2016-01-05 15:07:00-05:00,INFI,negative
666563.0,Stocks Hitting 52-Week Lows,2015-12-09 10:13:00-05:00,INFI,negative
666564.0,"Infinity Pharma Reports Q3 EPS $0.84, Sales $90.7M; Sees FY15 Sales $100M-$120M vs $97.5M Est.",2015-11-05 16:50:00-05:00,INFI,neutral
666565.0,Infinity Pharma Sees FY 2015 Revs $100M-$120M Vs Est $110.11M,2015-10-06 07:04:00-04:00,INFI,neutral
666566.0,Infinity Pharma Gives Update on IPI 549,2015-10-06 07:03:00-04:00,INFI,neutral
666567.0,Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study Evaluating Duvelisib In Indolent Non-Hodgkin Lymphoma,2015-09-30 09:03:00-04:00,INFI,neutral
666568.0,New Biotech Pair Trade: Infinity Pharma Over ImmunoGen,2015-09-21 10:41:00-04:00,INFI,neutral
666569.0,Benzinga's Top Upgrades,2015-09-21 09:01:00-04:00,INFI,positive
666570.0,"Morgan Stanley Upgrades Infinity Pharmaceuticals to Overweight, Lowers PT to $13.00",2015-09-21 04:29:00-04:00,INFI,negative
666571.0,A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month,2015-09-08 16:05:00-04:00,INFI,negative
666572.0,Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with CLL at ASCO,2015-05-31 09:50:00-04:00,INFI,neutral
666573.0,Infinity Shows Preclinical Data for Duvelisib Demonstrating Synergy with Standard-of-Care Therapies and Emerging Agents in Development for Treatment of Hematologic Malignancies,2015-05-26 08:02:00-04:00,INFI,neutral
666574.0,Stifel Talks 5 Biotech Stocks,2015-05-14 12:17:00-04:00,INFI,neutral
666575.0,Deutsche Sees Cancer Treatment Home Run At Infinity Pharmaceuticals,2015-05-07 16:52:00-04:00,INFI,negative
666576.0,Infinity Reaffirms FY Guidance,2015-05-07 13:38:00-04:00,INFI,neutral
666577.0,Benzinga's Top Initiations,2015-05-07 10:03:00-04:00,INFI,positive
666578.0,Deutsche Bank Initiates Infinity Pharmaceuticals With Buy,2015-05-07 09:50:00-04:00,INFI,neutral
666579.0,"Deutsche Bank Initiates Coverage on Infinity Pharmaceuticals at Buy, Announces $20.00 PT",2015-05-07 06:09:00-04:00,INFI,neutral
666580.0,Filing from Infinity Pharma Shows Registration for Automatic Mixed Securities Shelf Offering,2015-05-06 08:10:00-04:00,INFI,positive
666581.0,CAR-T Therapy Stocks Hit Hard Following AACR Data,2015-04-20 13:44:00-04:00,INFI,negative
666582.0,Infinity To report Preclinical Data Of Duvelisib Combined With Venetoclax At 2015 American Association For Cancer,2015-04-20 13:01:00-04:00,INFI,negative
666583.0,It's A Big Weekend For Biotech,2015-04-17 16:31:00-04:00,INFI,neutral
666584.0,Infinity Pharma. Names Sujay Kango Chief Commercial Officer,2015-04-14 08:10:00-04:00,INFI,neutral
666585.0,"Pandora, Sohu.com, Infinity Pharmaceuticals Lead Friday's After-Hours Movers",2015-04-10 19:01:00-04:00,INFI,neutral
666586.0,"Regulus Therapeutics, Healthcare Stocks Are Big Movers In Tuesday's After Hours Trading",2015-04-07 20:39:00-04:00,INFI,neutral
666587.0,JPM Securities Picks Through Biotech News For Winners,2015-02-25 12:41:00-05:00,INFI,positive
666588.0,UPDATE: Infinity Pharmaceuticals Posts Q4 Loss,2015-02-24 17:41:00-05:00,INFI,negative
666589.0,"Infinity Reports FY14 EPS $(0.36), Rev.$165M",2015-02-24 16:11:00-05:00,INFI,neutral
666590.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1,2015-01-12 08:55:00-05:00,INFI,neutral
666591.0,"Infinity Pharma Expecting FY15 Loss in $190-$210M Range, Sales in $105-$125M Range vs $96.5M Est.; Sees Three Studies of Duvelisib Starting This Year",2015-01-12 08:04:00-05:00,INFI,negative
666592.0,Morning Market Losers,2015-01-08 09:54:00-05:00,INFI,negative
666593.0,"Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday Morning",2015-01-08 09:00:00-05:00,INFI,neutral
666594.0,Benzinga's Top #PreMarket Losers,2015-01-08 08:22:00-05:00,INFI,negative
666595.0,Infinity Pharmaceuticals Phase 2 Study Of Duvelisib With Background Methotrexate In Patients With Moderate-To-Severe Rheumatoid Arthritis Did Not Meet Primary Endpoint,2015-01-08 06:58:00-05:00,INFI,neutral
666596.0,Morgan Stanley Downgrades Infinity Pharmaceuticals to Equalweight,2015-01-05 08:52:00-05:00,INFI,neutral
666597.0,Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib At ASH Annual Meeting,2014-12-09 11:30:00-05:00,INFI,neutral
666598.0,"Infinity Reports New Translational Research, Updated Phase 1 Data Of Investigational Oncology Compound Duvelisib At ASH Meeting",2014-12-08 10:46:00-05:00,INFI,neutral
666599.0,"Credit Suisse Upgrades Infinity Pharmaceuticals, Inc. to Outperform, Raises PT to $22.00",2014-12-04 04:30:00-05:00,INFI,positive
666600.0,Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented at ASH 2014 Annual Meeting,2014-11-06 09:06:00-05:00,INFI,neutral
666601.0,"Stifel Nicolaus Initiates Coverage on Infinity Pharmaceuticals, Inc. at Hold",2014-10-20 05:54:00-04:00,INFI,neutral
666602.0,Shares of Infinity Pharma to Resume Trade at 8 a.m. EDT,2014-10-16 07:42:00-04:00,INFI,positive
666603.0,"UPDATE: Infinity Pharma Shares Halted to Announce: Data Did Not Meet Primary Endpoint, Met Several Secondary, Exploratory Endpoints",2014-10-16 07:36:00-04:00,INFI,positive
666604.0,"Infinity Reports Topline Data From Phase 2a Exploratory Study Of Duvelisib In Patients With Mild, Allergic Asthma",2014-10-16 07:35:00-04:00,INFI,negative
666605.0,3 Partnerships Pushing The Pharmaceutical Sector Forward,2014-09-22 12:59:00-04:00,INFI,neutral
666606.0,Benzinga's Top Upgrades,2014-09-04 09:11:00-04:00,INFI,positive
666607.0,JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform,2014-09-04 07:04:00-04:00,INFI,positive
666608.0,"JMP Securities Upgrades Infinity Pharmaceuticals, Inc. to Market Outperform, Announces $24.00 PT",2014-09-04 06:07:00-04:00,INFI,positive
666609.0,"UPDATE: Infinity Pharmaceuticals Shares Rose 44% Wednesday, Following Announcement of Collaboration with AbbVie; On August 20, Benzinga Reported Unusual Activity in Infinity September $11 Call ",2014-09-03 17:09:00-04:00,INFI,positive
666610.0,"S&P 500 Struggles To Hold 2,000 As Commodities Rebound",2014-09-03 17:01:00-04:00,INFI,negative
666611.0,"Midday Gainers From Wednesday, September 3",2014-09-03 14:41:00-04:00,INFI,neutral
666612.0,NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With AbbVie,2014-09-03 13:01:00-04:00,INFI,neutral
666613.0,"Wedbush Upgrades Infinity Pharmaceuticals, Inc. to Neutral",2014-09-03 12:34:00-04:00,INFI,neutral
666614.0,Markets Gain; Toll Brothers Profit Beats Estimates,2014-09-03 11:22:00-04:00,INFI,positive
666615.0,Benzinga's Volume Movers,2014-09-03 10:27:00-04:00,INFI,neutral
666616.0,Morning Market Movers ,2014-09-03 09:43:00-04:00,INFI,neutral
666617.0,Benzinga's Top #PreMarket Gainers,2014-09-03 08:04:00-04:00,INFI,positive
666618.0,UPDATE: Infinity Pharmaceuticals Shares Rise 45% Premarket on Deal with AbbVie,2014-09-03 07:15:00-04:00,INFI,positive
666619.0,"Adam Feuerstein Tweeet: 'All jokes aside, $INFI IPI-145 was largely seen as discarded drug from Wall St. perspective, so the $ABBV deal is a real achievement'",2014-09-03 07:13:00-04:00,INFI,negative
666620.0,"Infinity, AbbVie Enter Global Strategic Collaboration to Develop and Commercialize Duvelisib In Oncology ",2014-09-03 06:46:00-04:00,INFI,neutral
666621.0,Infinity Announces Master Clinical Supply Agreement and Material Transfer Agreement with Roche ,2014-09-03 06:33:00-04:00,INFI,positive
666622.0,What You Need to Know About the Roche-InterMune Deal,2014-08-29 15:51:00-04:00,INFI,neutral
666623.0,Markets Open Higher; Burger King In Talks To Buy Tim Hortons,2014-08-25 11:41:00-04:00,INFI,neutral
666624.0,InterMune's Roche Deal Sends Peer Group Up,2014-08-25 11:38:00-04:00,INFI,neutral
666625.0,"Option Alert: Infinity Pharmaceuticals Sep $11 Call; 2,500 Contracts Traded vs 50 OI; Currently $10.67",2014-08-20 10:12:00-04:00,INFI,positive
666626.0,"Infinity Pharma Reports Will Commence Three Clinical Studies of IPI-145, Expecting Topline Data by Year End",2014-08-05 08:10:00-04:00,INFI,neutral
666627.0,"Infinity Pharmaceuticals, Inc. Reports Q2 EPS of $(0.78) vs $(0.84) Est",2014-08-05 08:09:00-04:00,INFI,neutral
666628.0,3 Small-Cap Biotechs That Institutions Are Loving,2014-07-07 14:54:00-04:00,INFI,positive
666629.0,UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals On Data Upside Driver,2014-06-25 09:40:00-04:00,INFI,neutral
666630.0,"Morgan Stanley Initiates Coverage on Infinity Pharmaceuticals, Inc. at Overweight, Announces $17.00 PT",2014-06-25 06:28:00-04:00,INFI,negative
666631.0,"Jefferies Upgrades Infinity Pharmaceuticals, Inc. to Buy, Lowers PT to $13.00",2014-05-07 09:13:00-04:00,INFI,negative
666632.0,"Infinity Pharmaceuticals, Inc. Reports Q1 EPS of $(0.87) vs $(0.83) Est",2014-05-06 16:26:00-04:00,INFI,neutral
666633.0,Amended 13G Filing from Point72 on Infinity Pharma Shows 7.1% Stake,2014-04-09 17:26:00-04:00,INFI,neutral
666634.0,"Wedbush Initiates Coverage on Infinity Pharmaceuticals, Inc. at Underperform, Announces $10.00 PT",2014-03-04 07:28:00-05:00,INFI,neutral
666635.0,"Nomura Maintains Neutral on Infinity Pharmaceuticals, Inc., Raises PT to $17.00",2014-02-26 08:46:00-05:00,INFI,neutral
666636.0,Infinity Reports Encouraging Phase 1 IPI-145 Data at Sixth Annual T-Cell Lymphoma Forum ,2014-01-23 16:28:00-05:00,INFI,positive
666637.0,"Nomura Initiates Coverage on Infinity Pharmaceuticals, Inc. at Neutral, Announces $14.00 PT",2014-01-08 07:48:00-05:00,INFI,neutral
666638.0,UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on Limited Clinical News in 2014,2013-12-12 09:02:00-05:00,INFI,positive
666639.0,Benzinga's Top Downgrades,2013-12-12 07:29:00-05:00,INFI,positive
666640.0,"Credit Suisse Downgrades Infinity Pharmaceuticals, Inc. to Neutral, Maintains $20.00 PT",2013-12-12 06:52:00-05:00,INFI,positive
666641.0,Mid-Day Market Update: Sysco Shares Rise Following Merger with US Foods; McDonald's Falls,2013-12-09 12:39:00-05:00,INFI,positive
666642.0,Benzinga's Volume Movers,2013-12-09 10:34:00-05:00,INFI,neutral
666643.0,Mid-Morning Market Update: Markets Rise; Covidien To Buy Given Imaging For $30/Share,2013-12-09 10:23:00-05:00,INFI,neutral
666644.0,Infinity Reports Encouraging Phase 1 IPI-145  Data at ASH,2013-12-08 10:35:00-05:00,INFI,positive
666645.0,Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH 2013,2013-12-07 11:16:00-05:00,INFI,neutral
666646.0,"Infinity Pharmaceuticals, Inc. Reports Q3 EPS of $(0.71) vs $(0.74) Est; Revenue of $0.00",2013-11-07 16:18:00-05:00,INFI,neutral
666647.0,"Option Alert: Infinity Pharmaceuticals December 15 Call; 1,625 Contracts Traded @$1.90; Currently $14.25",2013-10-15 10:25:00-04:00,INFI,positive
666648.0,Shares of Synta Pharma Down ~1.6% But Off Session Lows Under $6; Analyst Sees Downside on Infinity News,2013-09-25 12:49:00-04:00,INFI,negative
666649.0,Infinity Says Topline Data from Phase 2 Study of Hsp90 Inhibitor Did Not Meet Efficacy Endpoints,2013-09-25 08:04:00-04:00,INFI,negative
666650.0,UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals on Multiple Challenges Ahead,2013-09-24 10:55:00-04:00,INFI,positive
666651.0,Benzinga's Top Initiations,2013-09-24 07:44:00-04:00,INFI,positive
666652.0,"William Blair Initiates Coverage on Infinity Pharmaceuticals, Inc. at Market Perform, Announces $21.00 PT",2013-09-24 06:55:00-04:00,INFI,neutral
666653.0,"William Blair Initiates Coverage on Infinity Pharmaceuticals, Inc. at Market Perform",2013-09-23 16:28:00-04:00,INFI,neutral
666654.0,"Shares of Infinity Pharma Breaking Over $17.50 Level, Now Up 2.5+%",2013-07-17 12:03:00-04:00,INFI,positive
666655.0,UPDATE: Goldman Sachs Lowers PT on Infinity Pharmaceuticals on Multiple Negative Factors,2013-07-05 09:29:00-04:00,INFI,negative
666656.0,"Infinity Pharma Issues Phase 1 Data from Clinical Trial of IPI-145, Shows Tolerance",2013-06-24 07:49:00-04:00,INFI,positive
666657.0,Afternoon Market Gainers,2013-06-18 12:35:00-04:00,INFI,neutral
666658.0,Mid-Afternoon Market Update: Markets Trying to Close in the Green; SolarCity Falls,2013-06-04 16:02:00-04:00,INFI,neutral
666659.0,Afternoon Market Gainers,2013-06-04 14:35:00-04:00,INFI,neutral
666660.0,"Mid-Day Market Update: Stocks Pare Gains, G-III Apparel Surges On Q1 Results",2013-06-04 13:24:00-04:00,INFI,positive
666661.0,Infinity Pharmaceuticals Breaks Above $20 as Shares Rebound 21%,2013-06-04 12:43:00-04:00,INFI,positive
666662.0,Benzinga's Volume Movers,2013-06-04 11:01:00-04:00,INFI,neutral
666663.0,Hearing Morgan Stanley Defending Infinity Pharmaceuticals,2013-06-04 09:56:00-04:00,INFI,neutral
666664.0,Infinity Pharmaceuticals Spikes Higher,2013-06-04 09:44:00-04:00,INFI,neutral
666665.0,Benzinga's Top Pre-Market Gainers,2013-06-04 08:13:00-04:00,INFI,positive
666666.0,Infinity Pharmaceuticals Shares Rebound on Piper Defense,2013-06-04 08:09:00-04:00,INFI,positive
666667.0,Mid-Afternoon Market Update: Markets Recovering; Pandora Falls in Anticipation of Apple's Streaming Radio,2013-06-03 15:41:00-04:00,INFI,positive
666668.0,Mixed Response on Infinity Pharma as Shares Plunge Amid Phase I Data,2013-06-03 13:42:00-04:00,INFI,positive
666669.0,Afternoon Market Losers,2013-06-03 13:41:00-04:00,INFI,negative
666670.0,"Mid-Day Market Update: Markets Turn Mixed, Colonial Properties Gains On Acquisition News",2013-06-03 12:27:00-04:00,INFI,positive
666671.0,"Mid-Morning Market Update: Markets Rise, Cracker Barrel Posts Upbeat Earnings",2013-06-03 10:34:00-04:00,INFI,neutral
666672.0,"Shares of Infinity Pharma Plunge Amid Phase I Data, Mixed Response by Analysts: Wells Fargo Calls CLL Data 'Very Solid,' Piper Jaffray Calls Data 'Disappointing'",2013-06-03 10:28:00-04:00,INFI,positive
666673.0,Morning Market Losers,2013-06-03 09:55:00-04:00,INFI,negative
666674.0,Benzinga's Top Pre-Market Losers,2013-06-03 08:16:00-04:00,INFI,negative
666675.0,Infinity Presents Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO,2013-06-02 09:19:00-04:00,INFI,positive
666676.0,"Market Wrap for Wednesday, May 22: Stocks Pullback As Bernanke Says Bond Buying Could Slow",2013-05-22 16:19:00-04:00,INFI,neutral
666677.0,"Market Wrap for Thursday, May 16: A Small Pullback For U.S. Stocks as Economic Data Disappoints ",2013-05-16 16:17:00-04:00,INFI,negative
666678.0,Mid-Afternoon Market Update: Optimer Falls as Halozyme Rockets Upwards,2013-05-16 15:35:00-04:00,INFI,neutral
666679.0,"Mid-Day Market Update: US Stocks Fluctuate, Cisco Systems Up on Better-than-Expected Earnings",2013-05-16 13:38:00-04:00,INFI,neutral
666680.0,Infinity Pharma Shares Bounce as Wells Fargo Started Coverage at Outperform,2013-05-09 11:48:00-04:00,INFI,positive
666681.0,"Infinity Pharmaceuticals, Inc. Reports Q1 EPS of $(0.57) vs $(0.67) Est",2013-05-07 16:46:00-04:00,INFI,neutral
666682.0,"Goldman Sachs Initiates Coverage on Infinity Pharmaceuticals, Inc. at Neutral, Announces $42.00 PT",2013-05-07 06:45:00-04:00,INFI,neutral
666683.0,"First Manhattan Responds to VIVUS Board Additions, Says Board Still Needs Overhaul",2013-05-01 08:49:00-04:00,INFI,neutral
666684.0,13G Filing from SAC Capital on Infinity Pharma Shows 5% Stake,2013-04-16 16:24:00-04:00,INFI,neutral
666685.0,Infinity Pharma Prices 10M Shares at $40/Share,2013-04-11 08:03:00-04:00,INFI,positive
666686.0,Infinity Announces 8.5M Share Proposed Secondary Offering of Common Stock ,2013-04-09 16:13:00-04:00,INFI,positive
666687.0,Infinity Pharma VP Christopher Lindlom to Resign,2013-04-09 07:33:00-04:00,INFI,negative
666688.0,"JMP Securities Initiates Coverage on Infinity Pharmaceuticals, Inc. at Market Perform",2013-04-02 08:51:00-04:00,INFI,positive
666689.0,UPDATE: Stifel Nicolaus Raises PT to $50 on Infinity Pharmaceuticals; IPI-145 Reaches MTD,2013-03-06 13:10:00-05:00,INFI,positive
666690.0,"UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Infinity Pharmaceuticals on 4Q Results",2013-03-06 11:19:00-05:00,INFI,negative
666691.0,UPDATE: Jefferies Raises PT on Infinity Pharmaceuticals on IPI-145 Sales Potential,2013-03-06 09:15:00-05:00,INFI,neutral
666692.0,"JP Morgan Maintains Overweight on Infinity Pharmaceuticals, Inc., Raises PT to $53.00",2013-03-06 08:57:00-05:00,INFI,neutral
666693.0,"Jefferies Maintains Hold on Infinity Pharmaceuticals, Inc., Raises PT to $41.00",2013-03-06 08:19:00-05:00,INFI,neutral
666694.0,"Stifel Nicolaus Maintains Buy on Infinity Pharmaceuticals, Inc., Raises PT to $50.00",2013-03-06 08:14:00-05:00,INFI,neutral
666695.0,"Earnings Scheduled For March 5, 2013",2013-03-05 04:12:00-05:00,INFI,neutral
666696.0,"UPDATE: Piper Jaffray Assumes Coverage on Infinity Pharmaceuticals, Upgrades to Overweight",2013-03-01 09:04:00-05:00,INFI,negative
666697.0,"Piper Jaffray Upgrades Infinity Pharmaceuticals, Inc. to Overweight, Raises PT to $53.00",2013-02-28 16:11:00-05:00,INFI,negative
666698.0,6 Chart Set-ups to Watch on Wednesday,2013-02-20 13:08:00-05:00,INFI,neutral
666699.0,UPDATE: Morgan Stanley Initiates Infinity Pharmaceuticals at Overweight on Blood Cancer Drug Data,2013-02-19 07:27:00-05:00,INFI,negative
666700.0,"Morgan Stanley Initiates Coverage on Infinity Pharmaceuticals, Inc. at Overweight, Announces $47.00 PT",2013-02-19 06:13:00-05:00,INFI,negative
666701.0,UPDATE: JP Morgan Initiates Infinity Pharmaceuticals at Overweight on Positive Data,2013-01-31 08:20:00-05:00,INFI,positive
666702.0,Benzinga's Top Initiations,2013-01-31 07:59:00-05:00,INFI,positive
666703.0,"JP Morgan Initiates Coverage on Infinity Pharmaceuticals, Inc. at Overweight, Announces $42.00 PT",2013-01-31 06:46:00-05:00,INFI,neutral
666704.0,UPDATE: Credit Suisse Initiates Infinity Pharmaceuticals at Outperform on Risk/Reward  ,2013-01-15 09:46:00-05:00,INFI,positive
666705.0,"Credit Suisse Initiates Coverage on Infinity Pharmaceuticals, Inc. at Outperform, Announces $42.00 PT",2013-01-15 08:27:00-05:00,INFI,positive
666706.0,Infinity Sees FY13 Loss $115-125M,2013-01-07 08:04:00-05:00,INFI,negative
666707.0,The Best Small Cap Performers of 2012,2012-12-30 11:07:00-05:00,INFI,positive
666708.0,Stocks Hitting 52-Week Highs,2012-12-24 10:07:00-05:00,INFI,neutral
666709.0,"Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma",2012-12-24 08:09:00-05:00,INFI,neutral
666710.0,"Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium ",2012-12-24 08:09:00-05:00,INFI,positive
666711.0,Infinity Announces Closing of Public Offering and Exercise of Over-Allotment Option,2012-12-18 10:26:00-05:00,INFI,neutral
666712.0,Stocks Hitting 52-Week Highs,2012-12-14 10:15:00-05:00,INFI,neutral
666713.0,Infinity Pharma Prices 5.696M Shares at $26.33,2012-12-13 09:31:00-05:00,INFI,positive
666714.0,Infinity Announces Proposed Public Offering of Common Stock  ,2012-12-12 16:08:00-05:00,INFI,neutral
666715.0,"Mid-Afternoon Market Update: Markets Continue to Rise, Diamond Foods Falls",2012-12-10 15:26:00-05:00,INFI,positive
666716.0,Stifel Nicolaus Upgrades Infinity Pharma from Hold to Buy,2012-12-10 12:41:00-05:00,INFI,neutral
666717.0,Infinity Pharmaceuticals Rises 15% on Positive Phase 1 Data,2012-12-10 10:31:00-05:00,INFI,positive
666718.0,Infinity Pharma Shares Rebound Over $22 Following Phase I Data on IPI-145,2012-12-10 10:25:00-05:00,INFI,positive
666719.0,Infinity Pharmaceuticals Spikes Higher,2012-12-10 10:23:00-05:00,INFI,neutral
666720.0,Infinity Reports Phase 1 Data for IPI-145 at ACR/ARHP Supporting Development in Inflammatory Conditions,2012-11-12 08:06:00-05:00,INFI,positive
666721.0,UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold on Limited Upside   ,2012-11-07 07:37:00-05:00,INFI,negative
666722.0,"Jefferies & Company Downgrades Infinity Pharmaceuticals from Buy to Hold, Raises PT from $18 to $21",2012-11-07 05:52:00-05:00,INFI,neutral
666723.0,Infinity Pharmaceuticals Reports Q3 EPS $0.52 May Not Compare $-0.57 Est,2012-11-06 08:12:00-05:00,INFI,neutral
666724.0,Infinity Pharma Holders Could Sell 11.4M Shares,2012-09-28 16:42:00-04:00,INFI,positive
666725.0,Stocks Hitting 52-Week Highs,2012-09-12 10:49:00-04:00,INFI,neutral
666726.0,UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at Hold; Royalty Burden High  ,2012-08-24 11:20:00-04:00,INFI,negative
666727.0,Stifel Nicolaus Initiates Coverage on Infinity Pharmaceuticals at Hold,2012-08-24 08:39:00-04:00,INFI,neutral
666728.0,Infinity Prices Public Offering of 5.3 million Shares of Common Stock at Price of $14.50 per Share,2012-08-09 08:48:00-04:00,INFI,positive
666729.0,Infinity Prices 5.3M Shares at $14.50,2012-08-09 08:45:00-04:00,INFI,positive
666730.0,Infinity Announces Proposed Public Offering of Common Stock,2012-08-08 16:13:00-04:00,INFI,neutral
666731.0,UPDATE: Jefferies Raises PT to $18 on Infinity Pharmaceuticals on Data Outlook  ,2012-08-08 13:08:00-04:00,INFI,neutral
666732.0,"Jefferies & Company Maintains Infinity Pharmaceuticals at Buy, Raises PT from $15 to $18",2012-08-08 06:20:00-04:00,INFI,neutral
666733.0,UPDATE: Infinity Cut 20% of Jobs,2012-08-07 08:13:00-04:00,INFI,negative
666734.0,Infinity Pharmaceuticals ReportsEPS $-0.54 May Not Compare to $-0.38 Est,2012-08-07 07:54:00-04:00,INFI,neutral
666735.0,"Social Media Outlook for Monday June 18 (BKS, A, INFI, DSW)",2012-06-18 14:19:00-04:00,INFI,neutral
666736.0,Infinity Pharmaceuticals Down 4% After Terminating Phase 2 Trials of Saridegib ,2012-06-18 14:18:00-04:00,INFI,neutral
666737.0,Infinity Pharmaceuticals Shuts Down Cancer Trials,2012-06-18 11:21:00-04:00,INFI,negative
666738.0,"Piper Jaffray Downgrades Infinity Pharmaceuticals from Overweight to Neutral, Lowers PT from $16 to $11.50",2012-06-18 11:02:00-04:00,INFI,negative
666739.0,Morning Market Losers,2012-06-18 09:52:00-04:00,INFI,negative
666740.0,Benzinga's Top Pre-Market Losers,2012-06-18 08:16:00-04:00,INFI,negative
666741.0,A Peek Into The Market Before The Trading Starts,2012-06-18 07:22:00-04:00,INFI,neutral
666742.0,Infinity Stops Phase 2 Trials of Saridegib in Chondrosarcoma and Myelofibrosis   ,2012-06-18 06:33:00-04:00,INFI,negative
666743.0,Infinity Added to NASDAQ Biotechnology Index  ,2012-05-15 08:06:00-04:00,INFI,neutral
666744.0,"Piper Jaffray Maintains Infinity Pharmaceuticals at Overweight, Raises PT from $12 to $16",2012-05-09 10:43:00-04:00,INFI,negative
666745.0,"Jefferies & Company Maintains Infinity Pharmaceuticals at Buy, Raises PT from $11 to $15",2012-05-09 07:00:00-04:00,INFI,neutral
666746.0,Infinity Pharma Reports Q1 EPS $(0.40) vs $(0.37) Est; Revenue $25.2M vs $26.18M Est,2012-05-08 16:01:00-04:00,INFI,neutral
666747.0,"Jefferies & Company Maintains Infinity Pharmaceuticals at Buy, Raises PT from $7 to $11",2012-03-14 06:45:00-04:00,INFI,neutral
666748.0,Infinity Provides Company Outlook; Reiterates 2012 Financial Guidance ,2012-03-13 16:04:00-04:00,INFI,neutral
666749.0,"Earnings Expectations for the Week of March 12 (URBN, ROST)",2012-03-11 11:04:00-04:00,INFI,neutral
666750.0,UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8,2012-01-27 14:37:00-05:00,INFI,negative
666751.0,Infinity Plummets on Disappointing Phase 2 Study,2012-01-27 10:58:00-05:00,INFI,negative
666752.0,Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8,2012-01-27 10:28:00-05:00,INFI,negative
666753.0,Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer   ,2012-01-27 06:47:00-05:00,INFI,negative
666754.0,Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI   ,2012-01-20 14:45:00-05:00,INFI,negative
666755.0,Rodman & Renshaw Initiates Infinity Pharmaceuticals at Market Perform,2012-01-05 07:59:00-05:00,INFI,neutral
666756.0,Infinity and Mundipharma Extend Global Strategic Alliance   ,2011-11-29 06:48:00-05:00,INFI,positive
666757.0,"Infinity Initiates Two Phase 1 Trials of IPI-145, a Potent Inhibitor of PI3K Delta and Gamma   ",2011-10-31 08:05:00-04:00,INFI,negative
666758.0,"Infinity Completes Enrollment in Phase 2 Trial of IPI-926, an Oral Smoothened Antagonist, in Pancreatic Cancer and Provides Additional Program Updates   ",2011-10-17 08:02:00-04:00,INFI,negative
666759.0,Infinity Pharmaceuticals Reports Q2 EPS $(0.44) vs $(0.36) Est,2011-08-09 16:01:00-04:00,INFI,neutral
666760.0,Stocks to Watch for Wednesday 7/20/2011: Fresh 52 Week Highs and Lows,2011-07-20 01:51:00-04:00,INFI,positive
666761.0,NASDAQ Stocks Hitting 52-Week Highs,2011-07-14 10:18:00-04:00,INFI,neutral
666762.0,"Infinity Expands Clinical Development Program for IPI-926, an Oral Smoothened Antagonist Targeting the Hedgehog Pathway",2011-06-22 08:04:00-04:00,INFI,negative
666763.0,Piper Jaffray Maintains Overweight on Infinity Pharmaceuticals,2011-06-07 07:55:00-04:00,INFI,negative
666764.0,"Piper Jaffray Reiterates Overweight Rating, $9 PT on Infinity Pharmaceuticals",2011-06-06 07:28:00-04:00,INFI,negative
666765.0,Piper Jaffray Reports On INFI As ASCO Abstracts Are Released,2011-05-19 08:02:00-04:00,INFI,neutral
666766.0,Jefferies & Company Reports on Infinity Pharmaceuticals (INFI),2011-05-11 08:05:00-04:00,INFI,neutral
666767.0,"Analysts Stock Upgrade And Downgrade For Mayl 10, 2011- SVNT, SVA, TLAB, INFI, LUV, GSIC, ARG, MTSC, ANF, TE, ASEI, SMT, DRWI, OXY, SPRD, CCIH",2011-05-10 08:22:00-04:00,INFI,neutral
666768.0,UPDATE: Piper Jaffray Upgrades Infinity Pharmaceuticals to Overweight (INFI),2011-05-09 09:13:00-04:00,INFI,negative
666769.0,"Benzinga's Top Upgrades (LUV, CCIH, INFI, SPRD)",2011-05-09 08:19:00-04:00,INFI,positive
666770.0,"Piper Jaffray Raises INFI Target From $6 To $9, Upgrades Shares To OW",2011-05-09 07:22:00-04:00,INFI,positive
666771.0,Piper Jaffray Reports Infinity Initiated Studies In Pancreatic Cancer And Chondrosarcoma,2011-04-05 07:27:00-04:00,INFI,negative
666772.0,"Earnings Scheduled For March 15 (AIR, DSW, SSRX, CRZO, BPZ, ESLT, RUE, BWS, INFI, ALXA, BWEN, CHDX, ATPG)",2011-03-15 03:02:00-04:00,INFI,neutral
666773.0,Infinity Provides 2011 Guidance  ,2011-01-07 08:08:00-05:00,INFI,neutral
666774.0,Infinity Pharma Reports Phase 1 Results On Oral Hedgehog Inhibitor IPI-926,2010-10-11 09:26:00-04:00,INFI,negative
666775.0,Piper Jaffray Gives BioPharma Weekly Outlook,2010-10-11 07:58:00-04:00,INFI,neutral
666776.0,INFI Shows Strong Cash Position After Weak 2Q,2010-08-05 10:21:00-04:00,INFI,positive
666777.0,"Infinity Pharmaceuticals, Inc. (INFI) Reports Results For The Fourth-Quarter",2010-02-11 12:44:00-05:00,INFI,neutral
